At-home test manufacturers faced unique challenges with forecasting demand, leading to supply and demand mismatches.
What happened
Let Supply Chain Dive's free newsletter keep you informed, straight from your inbox.
Why it matters
When Carri Chan wanted to stock up on at-home COVID-19 tests last summer, she went from one New York City pharmacy to the next. If she was lucky, they had one box.
She would buy it and go to the next pharmacy in search of more. Chan then ordered 12 sets, the maximum allowed on Amazon, in anticipation of the start of in-person school. She waited six to eight weeks for their arrival.
With young and unvaccinated children at home, Chan, a business professor of decision, risk and operations in the healthcare arena and the faculty director of the healthcare and pharmaceutical management program at the Columbia Business School, wanted the tests in case anyone in her household woke up with a sore throat.
This news brief is based on reporting published by Supply Chain Dive on 2022-04-12. The original report is linked below.
Supply Chain Dive
https://www.supplychaindive.com/news/covid-test-supply-chain-demand-planning-challenges/620255/This independent news brief is based on the public source identified above. It is an original summary or translation, not a reproduction of the source article. Rights in source text, research, trademarks and images remain with their respective owners; images are used under the licence or permission identified in the credit. Rights holders may contact rights@goodproductasia.com with evidence of ownership. Verified concerns will be corrected, replaced or removed promptly. This report is not investment, legal, medical or purchasing advice.
